Applied Research Systems Ars Holding N.v.

Istituto Farmacologico Serono S.p.a.

Instituto Fermacologio Serono Spa

Francesco Antonetti

Francesco Borrelli

Moshe Smolarsky

Fabrizio Martelli

Nachum Yonah

Ilana Belzer

Dany Suissa

Michel Dreano

There are provided monoclonal antibodies to the LDL receptor which are useful for the identification and purification of LDL and in treatment of e.g. hepatitis C infection.

Monoclonal antibodies to the human LDL receptor, their production and use

The toxic effects caused by anthraquinone drugs, particularly by antitumor anthraquinone drugs, are inhibited or reduced by administering Orgotein in a quantity sufficient to inhibit or reduce the superoxide radicals which are produced by the above mentioned drugs.

Reduction of the toxic effects caused by anthraquinone drugs

The association of a fibrinolytic agent and of a diffusion factor has been shown very useful in the treatment of myocardial infarction. It has been shown that it is very useful to administer urokinase and hyaluronidase in the quantity ratio of at least 8 to 1, the quantity of each compound being expressed in the appropriate international units.

Pharmaceutical composition containing a fibrinolytic agent and a

Growing community of inventors

Rome, Italy

Francesco Antonetti